Discharge for IMI2 Joint Undertaking Budget 2020

by name voted on 04.05.2022

Summary

The European Parliament reviews and grants discharge for the budget implementation of the Innovative Medicines Initiative 2 (IMI2) Joint Undertaking for the year 2020, noting both successful research outcomes and administrative concerns.

9 04.05.2022

Other

health

science

budgetary control

administrative law

public administration

research and intellectual property

Key points

The European Parliament grants discharge for the implementation of the 2020 budget of the Innovative Health Initiative Joint Undertaking.
The budget execution for both commitments and payments reached very high levels, exceeding 97%.
The organization made a significant contribution to the COVID-19 response by launching fast-track research projects.
There is a risk that administrative resources may become insufficient due to the long duration of research projects and increasing workloads.

Vote

PPE

S&D

Renew

Verts/ALE

ECR

ID

NI

The Left

Total

Speeches

58 Speeches in total

Pro

Contra

Gheorghe FALCĂ

Gheorghe FALCĂ

PPE

1:14 min

6. Discharge 2020 (debate)

Sira REGO

The Left

1:03 min

6. Discharge 2020 (debate)

Documents (PDFs)

REPORT on discharge in respect of the implementation of the budget of the Innovative Medicines Initiative 2 Joint Undertaking (now the Innovative Health Initiative Joint Undertaking) for the financial year 2020 Discharge 2020: Innovative Medicines Initiative 2 Joint Undertaking

These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.